Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Pediatrix Medical Group, Inc. (MD)
:MD
Earnings Data
Report Date
May 07, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
0.26Last Year’s EPS
0.2Same Quarter Last Year
Moderate Buy
Based on 3 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Feb 20, 2025
|% Change Since: 22.11%
|Next Earnings Date:May 07, 2025
Earnings Call Sentiment|Positive
The earnings call highlighted strong financial performance with significant improvements in cash flow and debt reduction. However, ongoing salary expense growth and economic uncertainties were noted as challenges. Overall, the company remains optimistic but cautious about its future prospects.Company Guidance
During the conference call, Pediatrix Medical Group, Inc. provided guidance for the fiscal year 2025, projecting an adjusted EBITDA between $215 million and $235 million. This expectation reflects a careful consideration of both headwinds and opportunities, following a year where 2024 adjusted EBITDA was approximately $220 million, excluding leap year effects. The company completed a portfolio restructuring, exiting practices that represented $200 million in annual revenue, and realized a $30 million annualized EBITDA benefit, of which one-third was recognized in 2024. The guidance also assumes full-year revenue of about $1.8 billion, a general and administrative expense range of $220 million to $230 million, and no anticipated contributions from mergers and acquisitions. Additionally, the company ended 2024 with a strong balance sheet, holding $230 million in cash and achieving a net debt of $386 million, translating to a net leverage of just over 1.7 times adjusted EBITDA.Strong Fourth Quarter and Year-End Results
The company finished 2024 with strong fourth quarter results, driven by favorable payer mix and positive volume, resulting in an adjusted EBITDA of $69 million, significantly above expectations.
Successful Portfolio Restructuring
The company completed its portfolio restructuring on time, exiting practices that represented $200 million in annual revenue and improved operating efficiency.
Reduction in Net Debt
The company reduced its net debt to $386 million from $515 million as of September 30th, reflecting a net leverage of just over 1.7 times.
Strong Cash Flow Generation
The company generated $135 million in operating cash flow in the fourth quarter, a significant increase from $73 million in the prior year.
---
MD Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
MD Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Feb 20, 2025 | $14.11 | $17.23 | +22.11% |
| Nov 01, 2024 | $12.32 | $15.21 | +23.46% |
| Aug 06, 2024 | $7.62 | $8.97 | +17.72% |
| May 07, 2024 | $9.28 | $9.05 | -2.48% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Pediatrix Medical Group, Inc. (MD) report earnings?
Pediatrix Medical Group, Inc. (MD) is schdueled to report earning on May 07, 2025, TBA Not Confirmed.
What is Pediatrix Medical Group, Inc. (MD) earnings time?
Pediatrix Medical Group, Inc. (MD) earnings time is at May 07, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is MD EPS forecast?
MD EPS forecast for the fiscal quarter 2025 (Q1) is 0.26.
---